BIVV
Bioverativ Inc. Common Stock
BIVV
BIVV
Delisted
BIVV was delisted on the 8th of March, 2018.
445 hedge funds and large institutions have $5.89B invested in Bioverativ Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 148 increasing their positions, 149 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
38% less call options, than puts
Call options by funds: $13.6M | Put options by funds: $21.9M
Holders
445
Holding in Top 10
3
Calls
$13.6M
Puts
$21.9M
Top Buyers
| 1 | +$78.2M | |
| 2 | +$73.9M | |
| 3 | +$56.4M | |
| 4 |
Renaissance Technologies
New York
|
+$45.9M |
| 5 |
Goldman Sachs
New York
|
+$40.9M |
Top Sellers
| 1 | -$336M | |
| 2 | -$133M | |
| 3 | -$30.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.7M |
| 5 |
Two Sigma Advisers
New York
|
-$14.2M |